Mulmit

Monopar TherapeuticsMonopar Therapeutics

MNPR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-16,704,415-13,717,000
2024-12-310-16,161,721-15,586,000
2019-12-310-4,323,761-4,224,874
2018-12-310-3,331,147-3,227,932
2017-12-310-16,603,127-16,554,872

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-26RIOUX PATRICEActing Chief Medical Officer1,380
2026-08-26RIOUX PATRICEActing Chief Medical Officer1
2026-08-26RIOUX PATRICEActing Chief Medical Officer1,380
2026-08-26Tsuchimoto Kim R485
2026-08-26Tsuchimoto Kim R615
2026-08-26Tsuchimoto Kim R700
2026-08-26Tsuchimoto Kim R1,098
2026-08-26Tsuchimoto Kim R602
2026-08-26Tsuchimoto Kim R590
2026-08-25Anderson Raymond694
2026-08-25Anderson Raymond646
2026-08-25Anderson Raymond1,802

8-K events

FiledItems
2026-08-12Results of operations · Financial statements and exhibits
2026-07-22Regulation FD disclosure · Financial statements and exhibits
2026-06-30Regulation FD disclosure · Financial statements and exhibits
2026-06-26Regulation FD disclosure · Financial statements and exhibits
2026-06-23Submission of matters to a vote
2026-05-29Regulation FD disclosure · Financial statements and exhibits
2026-05-19Regulation FD disclosure · Financial statements and exhibits
2026-05-14Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…